Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Haemonetics Corp HAE

Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NYSE:HAE)

No current opinion is available.

Bullboard Posts (NYSE:HAE)

Blood Bags Market Trends 2022 | Demand and Future Scope 2027

According to the latest report by IMARC Group, titled “Blood Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and...
johnson021 - September 9, 2022

Anyone out there?????

Any one watching this one - I picked some up and saw the shares add $5 a share in a couple weeks - news out today and earning tomorrow. ...
garp14 - January 30, 2007

Hammered

Fairly concise message given to management of haemonetics today with a 19% drop in the share price. Personally I would say it was a tad...
kedh - April 24, 2003